Education
About Us
Working with TipRanks
Follow Us
Apyx Medical (DE:BOV)
:BOV
BOV Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.89 - €1.75
Previous CloseN/A
Volume0.00
Average Volume (3M)33.00
Market Cap
€36.76M
Enterprise Value€53.95M
Total Cash (Recent Filing)$16.47M
Total Debt (Recent Filing)$140.00K
Price to Earnings (P/E)―
Beta1.16
Next Earnings
Mar 13, 2025EPS Estimate
-0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding37,643,887
10 Day Avg. Volume0
30 Day Avg. Volume33
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.80
Price to Cash Flow (P/CF)-2.20
P/FCF Ratio0.00
Enterprise Value/Market Cap1.47
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.60
Enterprise Value/Ebitda-2.36
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering3
---
Apyx Medical News
PremiumCompany Announcements
Apyx Medical Appoints New Chief Operating Officer
PremiumCompany Announcements
Apyx Medical Reports Q3 Results and Restructuring
PremiumCompany Announcements
Apyx Medical’s Strategic Moves for Financial Stability
---
Bulls Say, Bears Say
Bulls Say
Market OpportunityBroader GLP-1 adoption could catalyze new demand for skin tightening treatments, positioning Apyx as one of the best companies to capitalize on this growing market.
Product DevelopmentApyx Medical announced it submitted a 510(k) for AYON, an all-in-one body contouring platform, ahead of schedule.
Bears Say
Financial ChallengesApyx remains unprofitable and faces near-term financing challenges that are expected to remain an overhang on shares.
---
Options Prices
Currently, No data available
---
Ownership Overview
1.82% Insiders
10.44% Mutual Funds
13.39% Other Institutional Investors
70.35% Public Companies and
Individual Investors
BOV FAQ
What was Apyx Medical’s price range in the past 12 months?
Apyx Medical lowest stock price was €0.89 and its highest was €1.75 in the past 12 months.
What is Apyx Medical’s market cap?
Apyx Medical’s market cap is €36.76M.
When is Apyx Medical’s upcoming earnings report date?
Apyx Medical’s upcoming earnings report date is Mar 13, 2025 which is tomorrow.
How were Apyx Medical’s earnings last quarter?
Apyx Medical released its earnings results on Nov 08, 2024. The company reported -€0.129 earnings per share for the quarter, beating the consensus estimate of -€0.17 by €0.041.
Is Apyx Medical overvalued?
According to Wall Street analysts Apyx Medical’s price is currently Overvalued.
Does Apyx Medical pay dividends?
Apyx Medical does not currently pay dividends.
What is Apyx Medical’s EPS estimate?
Apyx Medical’s EPS estimate is -0.15.
How many shares outstanding does Apyx Medical have?
Apyx Medical has 37,643,887 shares outstanding.
What happened to Apyx Medical’s price movement after its last earnings report?
Apyx Medical reported an EPS of -€0.129 in its last earnings report, beating expectations of -€0.17. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Apyx Medical?
Currently, no hedge funds are holding shares in DE:BOV
---
Apyx Medical Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
― (―)
― (―)
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.79%
12-Months-Change
Fundamentals
Return on Equity
-128.15%
Trailing 12-Months
Asset Growth
2.14%
Trailing 12-Months
Company Description
Apyx Medical
Apyx Medical Corp. operates as an energy-based medical technology company. It engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
---
BOV Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strategic initiatives such as the development of the Ayon platform and restructuring efforts to streamline operations and extend financial runway. Despite these positive steps and growth in disposable and OEM segments, the company faced challenges with declining revenue and sales in their Advanced Energy segment, attributed to macroeconomic factors. The sentiment is mixed as the company is taking proactive measures but currently faces significant market challenges.Read More>---
BOV Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering BOV
1 Year
1 Year Success Rate
4/28 ratings generated profit
1 Year Average Return
-29.57%
reiterated a buy rating 3 days ago
Copying Matt Hewitt's trades and holding each position for 1 Year would result in 18.52% of your transactions generating a profit, with an average return of -29.57% per trade.
---